NO851029L - Analogifremgangsmaate for fremstilling av terapeutisk aktive isokroman- og oksepinderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive isokroman- og oksepinderivater

Info

Publication number
NO851029L
NO851029L NO851029A NO851029A NO851029L NO 851029 L NO851029 L NO 851029L NO 851029 A NO851029 A NO 851029A NO 851029 A NO851029 A NO 851029A NO 851029 L NO851029 L NO 851029L
Authority
NO
Norway
Prior art keywords
group
atoms
hydrogen atom
atom
chlorine
Prior art date
Application number
NO851029A
Other languages
English (en)
Norwegian (no)
Inventor
Wolfgang Abele
Herbert Koeppe
Franz Esser
Wolfram Gaida
Wolfgang Hoefke
Ilse Streller
Richard Reichl
Werner Traunecker
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO851029L publication Critical patent/NO851029L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO851029A 1984-03-16 1985-03-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive isokroman- og oksepinderivater NO851029L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843409612 DE3409612A1 (de) 1984-03-16 1984-03-16 Neue substituierte isochromane und oxepine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
NO851029L true NO851029L (no) 1985-09-17

Family

ID=6230653

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851029A NO851029L (no) 1984-03-16 1985-03-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive isokroman- og oksepinderivater

Country Status (18)

Country Link
EP (1) EP0157206A3 (enrdf_load_html_response)
JP (1) JPS60209581A (enrdf_load_html_response)
KR (1) KR850006397A (enrdf_load_html_response)
AU (1) AU4001785A (enrdf_load_html_response)
CS (1) CS247196B2 (enrdf_load_html_response)
DD (1) DD234421A5 (enrdf_load_html_response)
DE (1) DE3409612A1 (enrdf_load_html_response)
DK (1) DK120185A (enrdf_load_html_response)
ES (1) ES8606324A1 (enrdf_load_html_response)
FI (1) FI851022A7 (enrdf_load_html_response)
GR (1) GR850658B (enrdf_load_html_response)
HU (1) HUT37419A (enrdf_load_html_response)
IL (1) IL74616A0 (enrdf_load_html_response)
NO (1) NO851029L (enrdf_load_html_response)
PH (1) PH20880A (enrdf_load_html_response)
PL (1) PL252375A1 (enrdf_load_html_response)
PT (1) PT80115B (enrdf_load_html_response)
ZA (1) ZA851948B (enrdf_load_html_response)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
JPH03178952A (ja) * 1989-06-23 1991-08-02 Kyowa Hakko Kogyo Co Ltd アリールアルキルアミン誘導体
EP0450689A1 (en) * 1990-04-02 1991-10-09 Akzo Nobel N.V. New isochromane derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives

Also Published As

Publication number Publication date
DD234421A5 (de) 1986-04-02
IL74616A0 (en) 1985-06-30
EP0157206A2 (de) 1985-10-09
KR850006397A (ko) 1985-10-05
DE3409612A1 (de) 1985-09-19
DK120185A (da) 1985-09-17
HUT37419A (en) 1985-12-28
PL252375A1 (en) 1985-10-22
JPS60209581A (ja) 1985-10-22
ZA851948B (en) 1986-11-26
AU4001785A (en) 1985-09-19
FI851022L (fi) 1985-09-17
ES541295A0 (es) 1986-04-01
EP0157206A3 (de) 1986-06-11
PH20880A (en) 1987-05-27
FI851022A0 (fi) 1985-03-14
PT80115B (de) 1987-03-24
FI851022A7 (fi) 1985-09-17
GR850658B (enrdf_load_html_response) 1985-07-11
CS247196B2 (en) 1986-12-18
PT80115A (de) 1985-04-01
DK120185D0 (da) 1985-03-15
ES8606324A1 (es) 1986-04-01

Similar Documents

Publication Publication Date Title
RU2091379C1 (ru) Дифенилметилпиперазиновые производные или их фармацевтически приемлемая соль
FR2581993A1 (fr) Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
NO155490B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 4-)1"-hydroksy-2"-(n-imidazolyl)etyl)bibenzyl.
US4889858A (en) Dibenz[b,e]oxepin derivatives and pharmaceutical composition containing the same
US4935414A (en) New indolylpropanols, processes for their preparation and their use, and preparations containing the compounds
EP0816338A1 (en) 3-(bis-substituted-phenylmethylene)oxindole derivatives
AU610294B2 (en) Amino acid esters of 4-alkoxy-5-arylhydroxymethyl-2-(5h)- furanone
NO149502B (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive aminoalkoksyfenylderivater.
JPH01106839A (ja) アルカジエン誘導体類、それらの製造、およびそれらを含有している薬学的組成物
NO851029L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokroman- og oksepinderivater
CZ279282B6 (cs) Způsob přípravy 1-/(diarylmethoxy)- alkyl/ pyrrolidinů a piperidinů
US4140790A (en) 3-(4-Substituted piperazino)-1-xanthene-9-carbonyloxy-propanes
GB2171997A (en) 4-Amino-6,7-dimethoxy-2-Piperazin-1-ylquinazoline derivatives
DK167974B1 (da) 1-(phenylalkyl)-3-(3-hydroxyphenyl)piperidin-forbindelser fremgangsmaade til fremstilling deraf og 3-(3-methoxyphenylpiperidin-forbindelser til anvendelse som mellemprodukter ved deres fremstilling samt farmaceutiske praeparater indeholdende de foerstnaevnte forbindelser
NO820291L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
SU893133A3 (ru) Способ получени производных 1-/3-(3,4,5-триметоксифенокси)-2-пропил/-4-арилпиперазина
Albrecht et al. Enantio-and Diastereoselective Synthesis of β, γ, γ, δ-Tetrasubstituted α-Methylene-δ-lactones
US4421754A (en) Syndonimine derivatives, process for production thereof, and use thereof
SU1176837A3 (ru) Способ получени алкоксиметилпиразинов
EP0071175A2 (de) Phenylalkyloxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel
US3971798A (en) Pyridine derivative, processes of preparation and pharmaceutical compositions
KR910006987B1 (ko) 아미노에틸 이미다졸의 제조방법
EP0481253B1 (de) Neue p-Oxibenzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
Chapman et al. Synthesis and 13C NMR spectra of cis‐and trans‐{2‐(haloaryl)‐2‐[(1H‐imidazol)‐1‐yl] methyl]}‐1, 3‐dioxolane‐4‐methanols
CA2117075A1 (en) Quinazoline derivatives and their preparation